$YICCNeutralMed

Yorkville International Capital Corp. Announces Pricing of $200,000,000 Initial Public Offering

Yorkville International Capital Corp. priced its IPO of 20,000,000 units at $10.00 each, raising $200 million. Each unit includes one Class A share and one-third of a redeemable warrant; whole warrants allow buying shares at $11.50. Units trade on Nasdaq as YICCU from June 16, 2026, with shares and warrants expected to trade separately later. A 45-day over-allotment option covers up to 3,000,000 additional units.

7/10
8/10
Med
Neutral
Units begin trading June 16, 2026; expected close June 17, 2026.
Neutral—IPO pricing is specified, but no upside/downside thesis or demand signal is provided.

The IPO’s share listing under YICC is a direct new tradable event tied to the unit structure and separation schedule.

After unit separation, the Class A ordinary shares are expected to list on Nasdaq under symbol YICC once separate trading begins.

Potential repricing at/after separate trading as warrants detach and the share-only float/valuation changes.

Background

Yorkville International Capital Corp. is a blank check company incorporated in the Cayman Islands, seeking a merger/business combination with an emphasis on emerging markets, particularly Latin America and Venezuela.

Why it matters

The article is a primary IPO disclosure: it sets the unit price ($10.00), unit composition (Class A share + 1/3 redeemable warrant), warrant strike ($11.50), expected Nasdaq symbols for units and for separate trading, and the expected close date.

Market relevance

Provides concrete IPO terms and the start of trading/symbols for the unit, shares, and warrants—actionable for positioning around listing and separation mechanics.

Market effects

Adds a new blank-check (SPAC-style) listing with warrant structure; may modestly affect near-term supply/demand for IPO warrants/units on Nasdaq.

Limited—company is incorporated in the Cayman Islands but IPO mechanics are US-market focused (Nasdaq listing).

Low—no cross-border deal, regulator action, or macro shock beyond the IPO itself.

Alternative perspectives

Because this is a blank-check company with no target selected, post-IPO trading may be driven more by warrant/share mechanics than by fundamentals, reducing directional conviction.

Traders should focus on unit-to-separate-trading timing, warrant redemption/adjustment provisions (not detailed here), and how the over-allotment option (up to 3,000,000 units) could affect float and spreads.

Key entities

  • Yorkville International Capital Corp.

    Blank check company pricing its IPO of 20,000,000 units and disclosing unit/warrant structure and expected Nasdaq symbols.

  • Nasdaq Stock Market

    Expected listing venue for the units (Global Market tier) and for separate trading of shares and warrants.

  • SEC

    Registration statement (Form S-1) declared effective June 15, 2026.

Related articles

$YICCMed

Yorkville International Capital Corp. Announces Closing of $230,000,000 Initial Public Offering

Yorkville International Capital Corp. said it closed its $230 million initial public offering, selling 23,000,000 units at $10.00 each, including 3,000,000 units from full underwriters’ over-allotment. Each unit includes one Class A share and one-third redeemable warrant; whole warrants trade separately. Units began Nasdaq trading June 16, 2026 under YICCU, with shares and warrants expected to list as YICC and YICCW.

$SKHYMedAI 8/10

SK Hynix Just Raised $26.5 Billion in the Biggest U.S. IPO Ever by a Foreign Company. Here's What It Signals for the AI Memory Boom.

SK Hynix priced a record $26.5 billion U.S. IPO, selling 177.9 million American depositary shares at $149 each. Shares began trading on Nasdaq under SKHY and closed at $168.01, up 12.8%. Proceeds fund new fabrication and packaging capacity. The article cites Counterpoint Research on HBM leadership and Micron’s recent revenue and margin surge.

$SKHYMedAI 8/10

SK Hynix Soars 13% in Nasdaq Debut After Record $26.5 Billion IPO

SK Hynix debuted on Nasdaq after a record $26.5 billion U.S. IPO, with its ADRs closing up 12.8% at $168.01 versus a $149 offer price. The ADR premium to Seoul shares reflects conversion restrictions. Proceeds will fund capacity expansion and EUV lithography machines. CEO Kwak Noh-jung warned of a potential supply shortage in 2027.